GB1498261A - Influenza vaccines - Google Patents
Influenza vaccinesInfo
- Publication number
- GB1498261A GB1498261A GB1290/75A GB129075A GB1498261A GB 1498261 A GB1498261 A GB 1498261A GB 1290/75 A GB1290/75 A GB 1290/75A GB 129075 A GB129075 A GB 129075A GB 1498261 A GB1498261 A GB 1498261A
- Authority
- GB
- United Kingdom
- Prior art keywords
- influenza
- components
- virus
- type
- cationic detergent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229960003971 influenza vaccine Drugs 0.000 title abstract 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 6
- 125000002091 cationic group Chemical group 0.000 abstract 3
- 239000003599 detergent Substances 0.000 abstract 3
- 241000712461 unidentified influenza virus Species 0.000 abstract 3
- 241000700605 Viruses Species 0.000 abstract 2
- 206010022000 influenza Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 230000006798 recombination Effects 0.000 abstract 2
- 238000005215 recombination Methods 0.000 abstract 2
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 abstract 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 abstract 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 abstract 1
- 229940001007 aluminium phosphate Drugs 0.000 abstract 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000000568 immunological adjuvant Substances 0.000 abstract 1
- 230000000415 inactivating effect Effects 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 239000002504 physiological saline solution Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Detergent Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH44774A CH589453A5 (US20100154141A1-20100624-C00001.png) | 1974-01-14 | 1974-01-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1498261A true GB1498261A (en) | 1978-01-18 |
Family
ID=4187233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1290/75A Expired GB1498261A (en) | 1974-01-14 | 1975-01-13 | Influenza vaccines |
Country Status (27)
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6793928B1 (en) | 1997-11-25 | 2004-09-21 | Duphar International Research Bv | Vaccines with an LTB adjuvant |
| WO2009029695A1 (en) * | 2007-08-28 | 2009-03-05 | Baxter International Inc. | Method for producing viral vaccines |
| WO2015071177A1 (en) | 2013-11-15 | 2015-05-21 | Novartis Ag | Removal of residual cell culture impurities |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2829089A1 (de) * | 1977-07-13 | 1979-02-01 | Sandoz Ag | Subunit-vakzine |
| JPH0688911B2 (ja) * | 1985-06-06 | 1994-11-09 | 国立予防衛生研究所長 | インフルエンザワクチン及びその製造方法 |
| TW570803B (en) * | 1997-04-09 | 2004-01-11 | Duphar Int Res | Influenza vaccine |
| DE19938767C2 (de) * | 1999-08-16 | 2002-10-24 | Tad Pharma Gmbh | Spaltimpfstoffe |
| AU2006310171B2 (en) * | 2005-11-01 | 2011-02-17 | Seqirus UK Limited | Cell-derived viral vaccines with low levels of residual cell DNA by beta-propiolactone treatment |
-
1974
- 1974-01-14 CH CH44774A patent/CH589453A5/xx not_active IP Right Cessation
-
1975
- 1975-01-06 NO NO750031A patent/NO143128C/no unknown
- 1975-01-06 FI FI750014A patent/FI54053C/fi not_active IP Right Cessation
- 1975-01-06 DK DK1475AA patent/DK140003B/da not_active IP Right Cessation
- 1975-01-07 SE SE7500130A patent/SE427238B/xx not_active IP Right Cessation
- 1975-01-10 NL NL7500301.A patent/NL166622C/xx not_active IP Right Cessation
- 1975-01-10 DE DE2500785A patent/DE2500785B2/de active Granted
- 1975-01-13 DD DD183614A patent/DD116239A5/xx unknown
- 1975-01-13 AT AT21475A patent/AT345449B/de not_active IP Right Cessation
- 1975-01-13 GB GB1290/75A patent/GB1498261A/en not_active Expired
- 1975-01-13 HU HU75SA2736A patent/HU173920B/hu not_active IP Right Cessation
- 1975-01-13 PH PH16702A patent/PH14458A/en unknown
- 1975-01-13 IL IL46426A patent/IL46426A/xx unknown
- 1975-01-13 PL PL1975177303A patent/PL93689B1/pl unknown
- 1975-01-13 CA CA217,790A patent/CA1049406A/en not_active Expired
- 1975-01-13 ES ES433759A patent/ES433759A1/es not_active Expired
- 1975-01-13 IE IE59/75A patent/IE40794B1/xx unknown
- 1975-01-13 YU YU58/75A patent/YU41289B/xx unknown
- 1975-01-14 CS CS75255A patent/CS191254B2/cs unknown
- 1975-01-14 BE BE152368A patent/BE824372A/xx not_active IP Right Cessation
- 1975-01-14 AU AU77305/75A patent/AU500250B2/en not_active Expired
- 1975-01-14 JP JP50006975A patent/JPS58407B2/ja not_active Expired
- 1975-01-14 ZA ZA00750259A patent/ZA75259B/xx unknown
- 1975-01-14 FR FR7501007A patent/FR2257305B1/fr not_active Expired
- 1975-01-14 SU SU752101722A patent/SU616997A3/ru active
-
1980
- 1980-10-09 HK HK563/80A patent/HK56380A/xx unknown
-
1981
- 1981-01-29 JP JP56012831A patent/JPS6035326B2/ja not_active Expired
- 1981-12-30 MY MY204/81A patent/MY8100204A/xx unknown
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6793928B1 (en) | 1997-11-25 | 2004-09-21 | Duphar International Research Bv | Vaccines with an LTB adjuvant |
| WO2009029695A1 (en) * | 2007-08-28 | 2009-03-05 | Baxter International Inc. | Method for producing viral vaccines |
| US8497112B2 (en) | 2007-08-28 | 2013-07-30 | Baxter International Inc. | Method for producing viral vaccines |
| RU2496519C2 (ru) * | 2007-08-28 | 2013-10-27 | Бакстер Интернэшнл Инк. | Способ получения препарата, содержащего вирусные антигены, и применение препарата |
| AU2008293513B2 (en) * | 2007-08-28 | 2013-11-21 | Nanotherapeutics, Inc. | Method for producing viral vaccines |
| WO2015071177A1 (en) | 2013-11-15 | 2015-05-21 | Novartis Ag | Removal of residual cell culture impurities |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2684792A (en) | Porcine reproductive respiratory syndrome vaccine and diagnostic | |
| BR9106374A (pt) | Vacina oral e processo de extrair uma imunoresponsta em um mamifero | |
| GB1498261A (en) | Influenza vaccines | |
| AU6489986A (en) | Thymidine kinase deletion mutants of bovine herpersvirus-1, vaccines against infectious bovine rhinotracheitis containing same and methods for the production and use of same | |
| KR850001700A (ko) | 단순 헤르페스 바이러스 서브유니트 왁진(Herpes Simplex Virus Subuait Vaccine)의 제조방법 | |
| US3674864A (en) | Process for stabilizing preparations of interfering viruses | |
| Bang | Filamentous forms of Newcastle virus | |
| Russell et al. | Cell cooperation in antibody responses to influenza virus. I. Priming of helper T cells by internal components of the virion | |
| ES8104405A1 (es) | Procedimiento para preparar una vacuna de virus de gripe | |
| GB1292803A (en) | Improvements relating to the production of antigens | |
| ES471615A1 (es) | Procedimiento para aislar los componentes de glicoproteina de paramixovirus | |
| ES430415A1 (es) | Un procedimiento para preparar una vacuna de virus de la gripe atenuado. | |
| Russell et al. | Mumps Viral Cytolysin: I. Action on Human Epithelial Cells in Tissue Culture | |
| GB1256457A (en) | Diethylaminoethyldextran (deae-d) as adjuvant for vaccines for active immunisation | |
| AU5573196A (en) | A pluripotent vaccine against enveloped viruses | |
| GB928807A (en) | Combined poliomyelitis-diphtheria-tetanus-pertussis antigen and methods for its manufacture | |
| GB953992A (en) | Vaccine products and method of preparing same | |
| GB1016586A (en) | Vaccine for immunization of dogs against distemper and hepatitis contagiosa canis | |
| Greer et al. | Electron microscope study of the interaction of vaccinia virus with macrophages from immunized and nonimmunized rabbits | |
| GB777018A (en) | Poliomyelitis vaccine products and methods for preparing the same | |
| Coggins et al. | Serological Comparison with Rabbit Antisera of Hog Cholera Virus and Bovine Virus Diarrhea Virus. | |
| PT100460A (pt) | Partiiculas derivadas de virus de herpes e vacinas que as contem | |
| GB1413401A (en) | Influenza vaccine | |
| 郭元吉 et al. | Influenza C virus isolated from pigs in China | |
| FR1246365A (fr) | Procédé de préparation de particules de forme sphéroïdale par polymérisation en suspension de monomères non saturés éthyléniques en milieu aqueux |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| 732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19940113 |